HHS reports increase in buprenorphine providers, naloxone prescriptions
The number of health care providers with waivers to prescribe buprenorphine for opioid use disorder increased 19% between October 2021 and September 2022 to 132,005, the Department of Health and Human Services announced today. HHS last April issued revised practice guidelines for administering buprenorphine to treat OUD, which eased requirements for clinicians to obtain a waiver to treat OUD patients with buprenorphine. According to HHS, pharmacy-filled prescriptions for the overdose reversal drug naloxone also increased 37% over the period, from a three-month average of 109,414 prescriptions in October 2021 to 150,213 in August 2022.
Related News Articles
Headline
The Centers for Medicare & Medicaid Services May 20 released a proposed rule that would modify policies governing Medicaid state-directed…
Headline
The AHA has won two Telly Awards for its three-part video series, Voices of Leadership: Breaking Mental Health Stigma. The Telly Awards, a global…
Headline
The White House May 18 announced an expansion of TrumpRx.gov, which now features more than 600 generic drugs. The direct-to-consumer platform serves as a hub…
Headline
A KFF analysis published May 19 examined early indicators of how the expiration of the enhanced premium tax credits has impacted effectuated enrollment levels…
Headline
The Centers for Medicare & Medicaid Services May 15 released its 2027 final standards for the health insurance marketplaces, including the issuers and…
Headline
A blog by Noah Isserman, AHA director of health insurance and coverage policy, explains why Anthem’s nonparticipating provider policy limits patients’ …